Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

August 04, 2015 5:55 AM ET

Healthcare Equipment and Supplies

Company Overview of REVA Medical, Inc.

Company Overview

REVA Medical, Inc., a development stage medical device company, focuses on the commercialization of minimally invasive medical devices for the treatment of coronary artery disease in the human heart. It is developing and testing a bioresorbable stent to treat vascular disease in humans under the Fantom scaffolds name. The company was formerly known as MD3, Inc. and changed its name to REVA Medical, Inc. in March 2002. REVA Medical, Inc. was founded in 1998 and is headquartered in San Diego, California.

5751 Copley Drive

San Diego, CA 92111

United States

Founded in 1998

51 Employees





Key Executives for REVA Medical, Inc.

Co-founder, Chairman and Chief Executive Officer
Age: 61
Total Annual Compensation: $430.5K
President and Chief Operating Officer
Age: 58
Total Annual Compensation: $447.1K
Chief Financial Officer and Company Secretary
Age: 56
Total Annual Compensation: $515.2K
Senior Vice President of Clinical and Regulatory Affairs
Age: 48
Total Annual Compensation: $353.7K
Senior Vice President of Product Development
Age: 55
Total Annual Compensation: $348.7K
Compensation as of Fiscal Year 2014.

REVA Medical, Inc. Key Developments

REVA Medical, Inc. Announces Unaudited Consolidated Cash Flow Results for the Second Quarter and Year to Date Ended June 30, 2015

REVA Medical, Inc. announced unaudited consolidated cash flow results for the second quarter and year to date ended June 30, 2015. For the quarter, the company reported net operating cash outflow of USD 4,476,000. For the year to date, the company reported net operating cash outflow of USD 9,437,000.

REVA Medical, Inc. Releases Initial Clinical Results for Fantom Scaffold

REVA Medical, Inc. released initial clinical data on a subset of patients treated with the Fantom sirolimus-eluting bioresorbable scaffold at the Paris Course on Revascularization (EuroPCR). The FANTOM I pilot clinical trial, which enrolled patients with the Fantom scaffold at two clinical sites in Brazil and Poland, was designed to provide early clinical data on the device. In these patients acute performance was demonstrated with 100% technical and procedural success and no reported Major Adverse Cardiac Events (MACE) to date, with no incidence of ischemic target lesion revascularization (TLR), myocardial infarction (heart attack) or stent thrombosis. REVA is currently enrolling patients in the FANTOM II trial, which is designed to provide the necessary data for a European CE Mark application of Fantom.

Reva Medical, Inc. Expands FANTOM II Clinical Trial to Australia

REVA Medical, Inc. announced that the FANTOM II clinical trial is now enrolling patients with the Fantom sirolimus-eluting bioresorbable scaffold in Australia. This is in addition to previously announced sites in Brazil and Europe. The Fantom scaffold, made from REVA's advanced proprietary polymer, is designed to allow the restoration of blood flow in patients being treated for coronary artery disease, then resorb from the body over time. The FANTOM II trial is enrolling patients to support a European CE Mark application, which is expected to occur by mid-2016.

Similar Private Companies By Industry

Company Name Region
STARR Life Sciences Corp. United States
Endovasc-TissueGen-Blumberg Research Sponsors LLC United States
Osmetech, Inc. United States
Dental Photonics, Inc. United States
Starch Medical Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REVA Medical, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at